Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Granule Moisture Content Testing Before Compression – V 2.0

Posted on By

Tablets: SOP for Granule Moisture Content Testing Before Compression – V 2.0

Standard Operating Procedure for Granule Moisture Content Testing Before Compression

Department Quality Control
SOP No. SOP/TAB/127/2025
Supersedes SOP/TAB/127/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for testing the moisture content of granules before compression, ensuring that the granules meet the required moisture specifications for further processing.

2. Scope

This SOP applies to the testing of moisture content in granules before compression during tablet manufacturing, ensuring optimal moisture levels for compression and subsequent tablet quality.

3. Responsibilities

  • Quality Control (QC): Responsible for performing moisture content tests on granules, recording the results, and ensuring that the moisture content is within the required specifications.
  • Granulation Operator: Responsible for taking samples of the granules and providing them to QC for moisture testing during the granulation process.
  • Quality Assurance (QA): Ensures that moisture content testing is conducted according to this SOP and reviews the results for compliance with specifications.

4. Accountability

The QC Manager is accountable for ensuring that moisture content testing is performed accurately and according to this SOP. The QA Manager is responsible for reviewing the results to ensure

compliance with internal and regulatory standards.

See also  Tablets: SOP for Physical Testing of Immediate Release Tablets - V 2.0

5. Procedure

5.1 Sample Collection

  1. During the granulation process, collect a representative sample of the granules at regular intervals, typically every 15 minutes or after processing each set of granules.
  2. The sample size should be sufficient to ensure accurate results, typically 100 grams of granules per sample.

5.2 Moisture Content Testing Method

  1. Use the appropriate method for measuring moisture content, such as the loss on drying (LOD) method or a moisture analyzer, to measure the moisture level in the granules.
  2. If using the LOD method, weigh the sample and place it in a preheated oven at the prescribed temperature (typically 105°C) for a specified time (typically 1 hour) to remove moisture.
  3. Weigh the sample again after drying to calculate the moisture content based on the weight difference.
  4. If using a moisture analyzer, follow the manufacturer’s instructions to determine the moisture content directly.

5.3 Monitoring and Adjustments

  1. If the moisture content of the granules is outside the acceptable range (typically 2–4%), adjust the granulation process as necessary to achieve the desired moisture content.
  2. Adjustments may include increasing or decreasing the binder solution, altering drying time, or adjusting granulator settings to ensure optimal moisture content.
  3. After making adjustments, re-sample and re-test the granules to ensure that the moisture content is within the required specification.
See also  Tablets: SOP for Cleaning of Packing Machines Between Batches - V 2.0

5.4 Monitoring Frequency

  1. Moisture content should be tested at regular intervals throughout the granulation process. Typically, testing is performed every 15 minutes or after processing every set of granules.
  2. If any irregularities or deviations are observed, increase the frequency of testing until the issue is resolved.

5.5 Documentation

  1. Record the following information for each moisture content test:
    • Sample number and time of collection
    • Moisture content measurement
    • Deviation from the target moisture content, if any
    • Adjustments made to the process, if applicable
  2. Document all test results and corrective actions taken in the batch record (Annexure-2).
  3. Ensure that all records are signed and dated by the responsible personnel and reviewed by QA for compliance.

5.6 Acceptance Criteria

  1. The moisture content of the granules should be within the specified range (typically 2–4% moisture content).
  2. If the moisture content is outside the acceptable limits, the batch may need to be rejected or reworked. Adjustments should be made to bring the granules within the required moisture range.

5.7 Post-Granulation Actions

  1. Once the granules meet the required moisture content, proceed with the next steps in tablet manufacturing, such as compression, coating, and packaging.
  2. Ensure that any adjustments made to the granulation process are recorded, and the equipment is cleaned and calibrated as required.
See also  Tablets: SOP for Robustness Testing of Analytical Methods for Tablets - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <731> – Loss on Drying (LOD)
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Specifications for Granule Moisture Content

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Granules had moisture content > 5% Adjusted binder solution and drying time John Doe

Annexure-2: Batch Record

Sample Number Moisture Content (%) Time of Test Action Taken
Sample 1 3.5 10:30 AM Accepted

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated sampling and testing procedures Improved uniformity checking QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Aerosol: SOP for Monitoring Machine Performance During Manufacturing – V 2.0
Next Post: Capsule: SOP for Encapsulation Trials Using New Fill Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version